Local websites
Businesses
Other websites
General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

More information

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Event calendar

  • May 08, 2013
    UBS Investor Day
    Milano, Italy

Company information

Read about Novartis leaders, acquisitions and more. »

Financial results

Find annual, quarterly and product sales and results.  »

Share data and analysis

Learn about Novartis share performance, dividend information, and visit our return on investment calculator »

Shareholder information

Find out about our purchase plan, Annual General Meeting, and more. »

Fixed-income securities

Learn about the fixed-income securities issued by Novartis. »

Alcon information center

Find information on the transaction between Novartis AG and Alcon, Inc. »

New investors

Familiarize yourself with the company, learn about our growth strategy, meet the management team, and find information on our key products and development pipeline »

Corporate governance

Read key documents that explain how Novartis is governed. »

Contacts and services

Find investor contacts, FAQs, downloads and other services. »

Latest news

Top links
Top downloads
Stock chart

Stock performance

Q1 results 2013

Novartis announced its results for the first quarter of 2013 on April 24 ›